MIVT'S BIO-COMPATIBLE MEDICAL COATING TECHNOLOGIES FEATURED IN FORTUNE 500 NANOTECHNOLOGY SPECIAL REPORT; BUSINESS MAGAZINE SPOTLIGHTS PLAN TO COMMERCIALIZE PROPRIETARY DEVICE COATINGS FOR $160 BILLION DRUG DELIVERY MARKETPLACE

MIV Therapeutics, a leading developer of next-generation biocompatible coatings and advanced drug delivery systems for cardiovascular stents and other implantable medical devices, has been featured in the current issue of Fortune 500 Magazine, in a special section that highlights the substantial promise of its nanotechnology-based implant coating applications. Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=311656)